Teva Called Out for Complaint Handling, Written Procedures By Sam | December 20, 2019 The FDA hit Teva with a Form 483 for its handling of complaints and other deficiencies at its facility in Jerusalem, Israel. Source: Drug Industry Daily Posted in Drug Industry Daily